Why is Remedium Life falling/rising?

As of 11-Sep, Remedium Lifecare Ltd's stock price is currently at 1.52, reflecting an increase of 0.04 or 2.7%. The stock has been gaining momentum, having outperformed its sector by 2.99% today and achieving a consecutive gain over the last two days, with a total return of 5.56% during this period. Despite this short-term positive movement, the company faces significant challenges, including a high Debt to EBITDA ratio of -1.00 times and a reported decline in net sales of -76.36%. These factors contribute to a negative outlook, as the company has experienced losses and negative returns on capital employed, indicating poor long-term growth potential.
In the broader market context, Remedium Lifecare's short-term performance of +15.15% over the past week significantly outpaces the Sensex's gain of +1.03% during the same period. However, it is important to note that the stock has underperformed the market over the past year, with a decline of -77.69% compared to the Sensex's modest increase of +0.03%. This stark contrast highlights the stock's volatility and the risks associated with its financial health, despite recent positive price movements.